Inventor · disambiguated record
Mark Mendonca
Also filed as: MENDONCA MARK
3 granted patents·4 pending applications·20 citations·filing 2017–2024
66Inventor score
Top patents by PatentIndex Score
7 records- 0192US10562968B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 18, 2020·18 cites·19 claims
- 0289US11884722B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Granted Jan 30, 2024·1 cites·25 claims
- 0381US11685777B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jun 27, 2023·1 cites·9 claims
- 0478US2024343796A1Anti- gprc5d antibodies, bispecific antigen binding molecules that bind gprc5d and cd3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0563US2025066728A1Compositions and Methods for Generating Gamma-Delta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0654US2022333073A1Compositions and Methods for Generating Gamma-Delta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0751US2022333074A1Compositions and Methods for Generating Alpha-Beta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Mendonca files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →